The forecasted sales of Blood and Blood Forming Organs Medicine in Canada from 2024 to 2028 show a consistent annual decline, with the percentage of total sales dropping from 3.8% in 2024 to 3.5% by 2028. This indicates an annual decrease rate of around 2.7% year-on-year over the first four years. The compound annual growth rate (CAGR) from 2024-2028 demonstrates a negative trend of approximately 1.97% annually, reflecting a gradual decrease in reliance or demand for this category.
Future Trends to Watch for:
• Observe new market entrants or innovations that might disrupt the current trend.• Monitor the impact of healthcare policy changes or technological advancement on the demand and supply of blood-related medicines.• Consider demographic shifts, such as an aging population, which could alter future sales dynamics.
